Drugs
LONDON and SOUTH SAN FRANCISCO, CA: LONDON and SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 01/09/13 -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a regulatory application in the ...
SOUTH SAN FRANCISCO, CA and BOLOGNA, ITALY: SOUTH SAN FRANCISCO, CA and BOLOGNA, ITALY -- (Marketwire) -- 01/08/13 -- Theravance, Inc. (NASDAQ: THRX) and Alfa Wassermann S.p.A. announced today the initiation of a Phase 2 proof-of-concept study ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/07/13 -- . (TSX VENTURE: SBM) announced today its skin lightening compounds, TFC-849 and TFC-723, were proven to be non-genotoxic in an industry stan ...
BRIDGEWATER, NJ: BRIDGEWATER, NJ -- (Marketwire) -- 01/07/13 -- Aptalis Pharma, Inc., a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis (CF), announced the results of ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 01/07/13 -- Thallion Pharmaceuticals Inc. (TSX VENTURE: TLN) ("Thallion") today announced that it received a binding, final award (the "Final Award ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 01/07/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced its anticipated 2013 initial revenue, earnings per share (EPS) and year-end cash guidance, ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 01/02/13 -- NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases o ...
CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 12/27/12 -- Tonix Pharmaceuticals Holding Corp. (OTCQB: TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing novel treat ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 12/17/12 -- Sirona Biochem Corp. (TSX VENTURE: SBM) (the "Company") announced today that it has granted to directors, officers, consultants, ...
MARSEILLE, FRANCE: MARSEILLE, FRANCE -- (Marketwire) -- 12/17/12 -- Innate Pharma SA (EURONEXT PARIS: IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, today announ ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 12/11/12 -- Theravance, Inc. (NASDAQ: THRX) announced the initiation of a dose ranging Phase 2b study with TD-4208 as a nebulized aqueous solution in patien ...
BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 12/10/12 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to tr ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 12/07/12 -- . (TSX VENTURE: SBM), announced its for Type 2 diabetes reduced blood glucose more effectively than Johnson and Johnson's , an advance ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 12/05/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Chief Executive Officer, will present a corporate overview and busi ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 12/04/12 -- . (TSX VENTURE: SBM)(PINKSHEETS: SRBCF)(FRANKFURT: ZSB), an award-winning biotech company, announced today the results from an independent s ...
RESTON, VA: RESTON, VA -- (Marketwire) -- 12/04/12 -- Parabon NanoLabs, Inc. announced today that it has received a joint grant award from the National Science Foundation (NSF) for a project with Janssen Researc ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 12/04/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that its newly created anti-counterfeiting Pharma-Comb Void label for ZADAXIN has won the ...
PISCATAWAY, NJ: PISCATAWAY, NJ -- (Marketwire) -- 11/29/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that its Board of Directors has authorized a special dividend of $2.00 per common share, payab ...
